Glenmark Pharma profit after tax rises marginally to Rs 279 crore in Q2 Ruchika Sharma13 Nov 2022 12:00 PM ISTNew Delhi: Drugmaker Glenmark Pharmaceuticals on Friday said its profit after tax (PAT) rose marginally to Rs 279 crore for the second quarter...
Glenmark Pharma gets USFDA nod for generic version of Buphenyl tablets Ruchika Sharma3 Nov 2022 11:15 AM ISTBUPHENYL is indicated as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of...
Glenmark unveils generic version of Gilenya Capsules in US Ruchika Sharma2 Nov 2022 2:30 PM ISTMumbai: Drugmaker Glenmark Pharmaceuticals Inc., USA, has recently announced the launch of Fingolimod Capsules, 0.5 mg in the US. The...
CDSCO panel tells Glenmark to submit complete clinical trial report on antidiabetic FDC Drug Dr. Nandita Mohan24 Sept 2022 5:43 PM ISTIn response to drug major Glenmark proposal to manufacture and market the antidiabetic fixed dose combination Lobeglitazone Sulphate 0.5/0.5mg plus...
Health Bulletin 24/September/2022 Dr. Nandita Mohan24 Sept 2022 5:17 PM ISTHere are the top health news for the day:Submit complete CT Report: CDSCO tells Glenmark on antidiabetic FDC drugIn response to drug major Glenmark...
Glenmark Pharma North Carolina facility gets USFDA OAI status Ruchika Sharma25 Aug 2022 11:55 AM ISTMumbai: Glenmark Pharmaceuticals Limited has recently announced that the company has received Official Action Indicated (OAI) status from the US Food...
Sun Pharma, Glenmark recall products in US Rahul Verma25 July 2022 5:28 PM ISTLeading drug makers Sun Pharma and Glenmark are recalling products in the US, the world's largest market for medicines, due to lapses in the...
Glenmark, Sun Pharma recall products in US over manufacturing issues Ruchika Sharma25 July 2022 11:33 AM ISTNew Delhi: Leading drug makers Sun Pharma and Glenmark are recalling products in the US, the world's largest market for medicines, due to lapses in...
Glenmark Pharma launches Sitagliptin and its FDCs for Type 2 diabetes in India Ruchika Sharma7 July 2022 3:28 PM ISTThe medicines will be available under the brand name SITAZIT, SITAZIT- M, SITAZIT- M ER and SITAZIT D.
Glenmark gets one USFDA observation for Aurangabad facility Ruchika Sharma2 July 2022 4:29 PM ISTNew Delhi: Glenmark Pharmaceuticals Limited has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with...
Glenmark gets CDSCO Panel nod to study antidiabetic FDC containing Dapagliflozin, Sitagliptin, Metformin Susmita Roy27 Jun 2022 6:15 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Glenmark receives 6 USFDA observations for Baddi facility Roshni Dhar24 Jun 2022 6:00 PM ISTDrugmaker, Glenmark Pharmaceuticals Ltd, has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with six...
